Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Fish and Richardson
Moodys
Daiichi Sankyo
Queensland Health
Harvard Business School

Generated: July 17, 2019

DrugPatentWatch Database Preview

Patent: 10,130,632

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,130,632
Title:Methods for treating renal disease
Abstract: The invention features methods for treating or reducing the likelihood of developing a renal disease by administering to a subject in need thereof an agent that decreases expression of a pathogenic APOL1. The agents of the method target various signaling pathways and decrease the level of the pathogenic APOL1 polypeptide.
Inventor(s): Friedman; David J. (Boston, MA), Pollak; Martin R. (Boston, MA)
Assignee: Beth Israel Deaconess Medical Center, Inc. (Boston, MA)
Application Number:14/646,055
Patent Claims:see list of patent claims

Details for Patent 10,130,632

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2016-05-27 ➤ Sign Up Beth Israel Deaconess Medical Center, Inc. (Boston, MA) ➤ Sign Up RX search
Abbvie Inc HUMIRA adalimumab VIAL 125057 002 2002-12-31 ➤ Sign Up Beth Israel Deaconess Medical Center, Inc. (Boston, MA) ➤ Sign Up RX search
Abbvie Inc HUMIRA adalimumab SYRINGE 125057 001 2002-12-31 ➤ Sign Up Beth Israel Deaconess Medical Center, Inc. (Boston, MA) ➤ Sign Up RX search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02 ➤ Sign Up Beth Israel Deaconess Medical Center, Inc. (Boston, MA) ➤ Sign Up RX Orphan search
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02 ➤ Sign Up Beth Israel Deaconess Medical Center, Inc. (Boston, MA) ➤ Sign Up RX Orphan search
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24 ➤ Sign Up Beth Israel Deaconess Medical Center, Inc. (Boston, MA) ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Federal Trade Commission
McKinsey
Queensland Health
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.